文献速递妇科肿瘤

哪些宫颈鳞癌患者可能从新辅助化疗中获益?

Which Patients With Cervical Squamous Cell Carcinoma Might Benefit From Neoadjuvant Chemotherapy?
PubMed 文献 · J Clin Oncol · 2018-04-18

本文为肿瘤学大查房系列文章,通过一例55岁宫颈鳞癌IB2期病例,引出诊断与治疗挑战,并回顾相关文献,总结作者建议的管理方法,以帮助读者将关键研究结果应用于临床实践。

要点

  • 病例为55岁绝经后女性,宫颈鳞癌IB2期,伴高血压及子宫肌瘤。
  • 临床检查及影像学未发现宫旁、阴道侵犯或淋巴结转移。
  • 文章旨在讨论宫颈鳞癌新辅助化疗的获益人群及管理策略。

核心结论

  • 文章通过病例和文献回顾,探讨宫颈鳞癌新辅助化疗的潜在获益人群及临床管理建议。

研究设计与样本

  • 肿瘤学大查房系列文章,基于一例宫颈鳞癌IB2期病例,结合文献回顾和作者经验总结。

主要发现

  • 病例为55岁女性,宫颈6cm肿块,活检为中分化鳞癌,FIGO IB2期,无宫旁、阴道或淋巴结转移。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A 55-year-old postmenopausal woman, gravida 5 para 5, with past medical history significant for hypertension, presented to the emergency department with profuse vaginal bleeding and a hemoglobin level of 9 g/dL. The biopsy from an irregular 6-cm cervical mass was consistent with moderately differentiated cervical squamous cell carcinoma. The physical examination did not reveal vaginal or parametrial extension of the tumor. Pelvic magnetic resonance imaging disclosed the known carcinoma, as well as a 9.2 × 7.7 × 6.7 cm anterior uterine fibroid (Fig 1). A staging positron emission tomography scan was negative for metastatic disease. After blood transfusion and vaginal packing, the patient was referred to discuss the immediate management of her newly diagnosed bleeding bulky cervical cancer. In the absence of parametrial or vaginal extension and in the absence of lymph node metastasis (both on clinical examination and imaging), she was classified as having International Federation of Gynecology and Obstetrics stage IB2 disease.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Mahmoud O, Einstein MH. Which Patients With Cervical Squamous Cell Carcinoma Might Benefit From Neoadjuvant Chemotherapy? J Clin Oncol. 2018. PMID: 29668367. doi:10.1200/JCO.2017.77.3416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。